Welcome to licensed pharmacies in Poland:

Non-prescription medicines delivery across Europe.

Frequently ordered: potency boosters (sildenafil OTC), quit smoking aids.

Ziuta (Anonymous, 37.248.172.) Warszawa 2 years ago

Does Vessel Due F protect against coronary heart disease?

Does vessel due f protect against coronary heart disease

1 answer

* required field

You can drag the photo file here.

* required field

Notify of a new answer.
Other messages will not be sent.

Katarzyna Domagała Pharmacist

2 years ago

Yes, Vessel Due F can protect against the development of coronary heart disease. The occurrence of coronary heart disease is influenced by many factors, e.g. changes in the coronary arteries, which hinder the proper transport of blood, so that the amount of oxygen entering the heart cells is too small, atherosclerosis of the coronary arteries, deposition in the arteries of products resulting from metabolic changes or coronary artery embolism. Sulodexide - the active substance of The drug Vessel Due F - thanks to the fact that it reduces the concentration of fibrinogen in the plasma - improves the properties of the blood, which can be altered in patients at risk of thrombosis. In addition, it has an anti-inflammatory effect by reducing the release of inflammatory mediators in the coronary vessels, protects vascular endothelial cells, stimulates their reconstruction by providing substrates for this process and inhibiting enzymes that degrade cells, and normalizes increased blood lipid levels. All of these components of Vessel Due F make it helpful for patients who require protection before coronary artery disease can occur. I am attaching a study that may be helpful: https://www.gdziepolek.pl/artykuly/problemy-z-sercem

Appreciate the answerer and highlight the question on the home page
User questions and answers that provide feedback about products are not verified for the purchase or use of the product. Companies often order anonymous comments to form positive opinions about their products, or negative ones about competitors. Therefore, be guided by the information in the pharmacists' responses in the first place.

Specialists